Concepedia

Rinat Yerushalmi

RY

56

Publications

7.6K

Citations

28

H-Index

2002

Active since

Affiliations

Rabin Medical Center(Current)

Tel Aviv University

BC Cancer Agency

Texas Oncology

The University of Texas MD Anderson Cancer Center

Rinat Yerushalmi is an author at Rabin Medical Center specializing in medicine, breast cancer, and oncology.

ORCID

Top concepts

Publications per year

2002–2023

56

Publications

56

Metastatic Behavior of Breast Cancer Subtypes

Hagen F. Kennecke, Rinat Yerushalmi, Ryan Woods et al. · Journal of Clinical Oncology · 2010 · 2.2K citations · Full text

Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation

Jennifer K. Litton, Hope S. Rugo, Johannes Ettl et al. · New England Journal of Medicine · 2018 · 2K citations · Full text

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

Karen A. Gelmon, Marc Tischkowitz, Helen Mackay et al. · The Lancet Oncology · 2011 · 1.1K citations

, , +9

Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial

Jennifer K. Litton, Sara A. Hurvitz, Lida A. Mina et al. · Annals of Oncology · 2020 · 372 citations · Full text

Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes

Rinat Yerushalmi, Karen A. Gelmon, Samuel Leung et al. · Breast Cancer Research and Treatment · 2011 · 135 citations

, , +2

Rows per page

1–5 of 56